UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2003
ATRIX LABORATORIES, INC.
Delaware | 0-18231 | 84-1043826 | ||
(State or other jurisdiction of incorporation) |
(Commission file number) |
(I.R.S. employer identification no.) |
2579 Midpoint Drive, Fort Collins, Colorado | 80525 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (970) 482-5868
Item 9. Regulation FD Disclosure (Item 12. Results of Operations and Financial Condition). | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EX-99.1 Press Release |
Item 9. Regulation FD Disclosure (Item 12. Results of Operations and Financial Condition).
The following information is furnished pursuant to Item 12. Results of Operations and Financial Condition and is furnished under Item 9. Regulation FD Disclosure in accordance with SEC Release No. 33-8216.
On April 25, 2003, Atrix Laboratories, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2003. A copy of the press release is furnished as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit are furnished to, but not filed with, the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ATRIX LABORATORIES, INC. | ||||
By: | /s/ Brian G. Richmond Brian G. Richmond Chief Financial Officer, Secretary and Treasurer |
Date: April 25, 2003
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Press Release dated April 25, 2003 |